Indications
After radiolabelling with sodium pertechnetate (99mTcsolution, the solution obtained is indicated for:
- Myocardial perfusion scintigraphy for the detection and localisation of coronary artery disease (angina pectoris and myocardial infarction) Assessment of global ventricular function. First-pass technique for determination of ejection fraction and/or ECG-triggered, gated SPECT for evaluation of left ventricular ejection fraction, volumes and regional wall motion.
- Scintimammography for the detection of suspected breast cancer when mammography is equivocal, inadequate or indeterminate.
- Localisation of hyperfunctioning parathyroid tissue in patients with recurrent or persistent disease in both primary and secondary hyperparathyroidism, and in patients with primary hyperparathyroidism scheduled to undergo initial surgery of the parathyroid glands.
Labelling activity
Maximum 15 GBq (405.41 mCi)
Shelf life
30 months
Shelf-life and storage conditions after radiolabelling
8 hours, Do not store above 25°C.
Registration number NL
RVG 131842
Registration number BE
BE 663329
Registration number LUX
2025010008
